# DaNAgreen CO.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/danagreen-co

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.danagreenbio.com
- Total disclosed funding: $6.7M
- Latest round: Series A (Dec 29, 2021)
- Investors on record: 6

## About

Located in Seoul, South Korea, DaNAgreen CO., LTD. focuses on creating advanced scaffolding solutions for three-dimensional cell culture, aiming to enhance research and development in biotechnology and food technology industries.DaNAgreen CO., LTD. was founded in 2017 and specializes in innovative scaffolding solutions for cell culture. It has completed a total of four funding deals, with the latest being a Series A round in December 2021, during which it raised KRW 8 billion. The CEO, Kiwoo Kim, leads the company, which is headquartered in Seoul, South Korea. DaNAgreen does not have any known parent companies or subsidiaries.DaNAgreen Co., Ltd. specializes in the development of innovative scaffolding solutions for three-dimensional cell culture, primarily through its flagship product, Protinet™. This extracellular matrix-like scaffold is engineered using DaNAgreen’s patented crosslinking technology, allowing scientists to effectively culture cells in a more biologically relevant 3D environment. The Protinet™ product line includes variants such as Protinet™-S, designed for clinical applications using autologous human serum, and Protinet™-P, tailored for the mass production of cultured meat from plant proteins. The company targets a diverse client base, including research institutions, healthcare providers, and food technology companies, with its products being utilized in various geographical markets, including North America and Europe.DaNAgreen generates revenue through direct sales of its Protinet™ products to a variety of clients, including academic researchers, clinical laboratories, and food technology firms. The company's transaction structure typically involves direct sales agreements where clients purchase scaffold products such as Protinet™-S for research purposes or Protinet™-P for cultured meat applications. Pricing structures are established based on the specific product type and its intended use, ensuring that clients receive tailored solutions for their needs. Regular transactions are expected as clients place orders for scaffolds, which can be produced in customized sizes or forms upon request, thus facilitating ongoing relationships and repeat business.In December 2021, DaNAgreen raised KRW 8 billion in Series A funding to support its growth initiatives. The company is focused on expanding its product line by developing new variants of Protinet™ designed for additional applications, targeting a release of these products within the next 18 months. Furthermore, DaNAgreen aims to penetrate new geographic markets in Asia and Europe by 2023, leveraging its recent funding to enhance market entry strategies and expand its operational capabilities.

## Funding rounds

- Series A, Dec 29, 2021, $6.7M — CJ Investment, Pathfinder H, JW Asset, Penture Invest, Lotte Ventures, iM Investment Partners

## Investors

- CJ Investment (https://capitalatlas.ai/funds/cj-investment) — Series A
- Pathfinder H (https://capitalatlas.ai/funds/pathfinder-h) — Series A
- JW Asset — Series A
- Penture Invest (https://capitalatlas.ai/funds/penture-invest) — Series A
- Lotte Ventures (https://capitalatlas.ai/funds/lotte-ventures) — Series A
- iM Investment Partners (https://capitalatlas.ai/funds/im-investment-partners) — Series A